MCID: MYC058
MIFTS: 28

Myocardial Infarction 2 malady

Genetic diseases (common), Cardiovascular diseases categories

Summaries for Myocardial Infarction 2

About this section
Sources:
34MalaCards
See all sources

Fully expand this MalaCard

Download this MalaCard
MalaCards: Myocardial Infarction 2 is related to myocardial infarction and acute myocardial infarction. An important gene associated with Myocardial Infarction 2 is MCI2 (Myocardial infarction, susceptiblity to, 2), and among its related pathways is A-beta Plaque Formation and APP Metabolism. The compounds delapril and manidipine have been mentioned in the context of this disorder. Affiliated tissues include heart and atrioventricular node.

Aliases & Classifications for Myocardial Infarction 2

About this section
Sources:
48OMIM
See all sources

Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Genetic diseases (common)
Anatomical: Cardiovascular diseases


Aliases & Descriptions:

myocardial infarction 2 48


Related Diseases for Myocardial Infarction 2

About this section
Sources:
18GeneCards, 19GeneDecks
See all sources

Graphical network of diseases related to Myocardial Infarction 2:



Diseases related to myocardial infarction 2

Symptoms for Myocardial Infarction 2

About this section

Drugs & Therapeutics for Myocardial Infarction 2

About this section
Sources:
6CenterWatch, 43NIH Clinical Center, 7ClinicalTrials
See all sources

Approved drugs:

Search CenterWatch for Myocardial Infarction 2

Drug clinical trials:

Search ClinicalTrials for Myocardial Infarction 2

Search NIH Clinical Center for Myocardial Infarction 2

Search CenterWatch for Myocardial Infarction 2

Genetic Tests for Myocardial Infarction 2

About this section

Anatomical Context for Myocardial Infarction 2

About this section
Sources:
34MalaCards
See all sources

MalaCards organs/tissues related to Myocardial Infarction 2:

34
Heart, Atrioventricular node

Animal Models for Myocardial Infarction 2 or affiliated genes

About this section

Publications for Myocardial Infarction 2

About this section
Sources:
53PubMed
See all sources

Articles related to Myocardial Infarction 2:

(show all 32)
idTitleAuthorsYear
1
Letter by Fresco regarding article "Primary angioplasty versus fibrinolysis in acute myocardial infarction: long-term follow-up in the Danish Acute Myocardial Infarction 2 trial". (21173360)
2010
2
Primary angioplasty versus fibrinolysis in acute myocardial infarction: long-term follow-up in the Danish acute myocardial infarction 2 trial. (20308618)
2010
3
Timing of ischemic onset estimated from the electrocardiogram is better than historical timing for predicting outcome after reperfusion therapy for acute anterior myocardial infarction: a DANish trial in Acute Myocardial Infarction 2 (DANAMI-2) substudy. (17584552)
2007
4
Use of emergency medical services in acute myocardial infarction and subsequent quality of care: observations from the National Registry of Myocardial Infarction 2. (12473545)
2002
5
Smoking and mortality following acute myocardial infarction: results from the National Registry of Myocardial Infarction 2 (NRMI 2). (11906686)
2002
6
A risk model derived from the National Registry of Myocardial Infarction 2 database for predicting mortality after coronary artery bypass grafting during acute myocardial infarction. (12088769)
2002
7
The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. (11376306)
2001
8
Death or nonfatal stroke in patients with acute myocardial infarction treated with tissue plasminogen activator. Participants in the National Registry of Myocardial Infarction 2. (11230850)
2001
9
Payer status and the utilization of hospital resources in acute myocardial infarction: a report from the National Registry of Myocardial Infarction 2. (10737281)
2000
10
Treatment and outcomes of left bundle-branch block patients with myocardial infarction who present without chest pain. National Registry of Myocardial Infarction 2 Investigators. (10987588)
2000
11
The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. (10824077)
2000
12
Impact of history of diabetes mellitus on hospital mortality in men and women with first acute myocardial infarction. The National Registry of Myocardial Infarction 2 Participants. (10856398)
2000
13
The association between the on-site availability of cardiac procedures and the utilization of those services for acute myocardial infarction by payer group. The National Registry of Myocardial Infarction 2 Investigators. (10492841)
1999
14
Early use of ACE inhibitors in the treatment of acute myocardial infarction in the United States: experience from the National Registry of Myocardial Infarction 2. National Registry of Myocardial Infarction 2 participants. (10569326)
1999
15
Reperfusion therapy for acute myocardial infarction: observations from the National Registry of Myocardial Infarction 2. (10423667)
1999
16
Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. (10413733)
1999
17
A comparison of the national registry of myocardial infarction 2 with the cooperative cardiovascular project. (10362189)
1999
18
Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. (9537341)
1998
19
Presenting characteristics, treatment patterns, and clinical outcomes of non-black minorities in the National Registry of Myocardial Infarction 2. (9817473)
1998
20
Management and outcomes for black patients with acute myocardial infarction in the reperfusion era. National Registry of Myocardial Infarction 2 Investigators. (9817474)
1998
21
Bundle-branch block and in-hospital mortality in acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. (9841600)
1998
22
Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. (9708461)
1998
23
Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2. (9786806)
1998
24
The prehospital electrocardiogram in acute myocardial infarction: is its full potential being realized? National Registry of Myocardial Infarction 2 Investigators. (9060884)
1997
25
Recurrent myocardial infarction. 2. Possibilities of prediction. (4029186)
1985
26
Thrombolytic therapy. A new strategy for the treatment of acute myocardial infarction (2). (6236369)
1984
27
Dissociation of the atrioventricular node in acute inferior wall myocardial infarction. 2. Longitudinal dissociation (dual atrioventricular nodal pathways). (648218)
1978
28
The clinical significance of bundle branch block complicating acute myocardial infarction. 2. Indications for temporary and permanent pacemaker insertion. (688580)
1978
29
Myocardial infarction. 2. (4844740)
1974
30
Management of dysrhythmias associated with acute myocardial infarction. 2. (5130352)
1971
31
Treatment of acute myocardial infarction. 2. Ventricular ectopic arrhythmias. (4194547)
1970
32
Diseases of the heart and blood-vessels. Recovery after myocardial infarction--2. (5941505)
1966

Variations for Myocardial Infarction 2

About this section

Expression for genes affiliated with Myocardial Infarction 2

About this section
Sources:
2BioGPS, 16Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Myocardial Infarction 2

Search GEO for disease gene expression data for Myocardial Infarction 2.

Pathways for genes affiliated with Myocardial Infarction 2

About this section
Sources:
51PathCards, 55R&D Systems
See all sources

Pathways related to Myocardial Infarction 2 according to GeneCards/GeneDecks:

idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.1PLAT, ACE

Compounds for genes affiliated with Myocardial Infarction 2

About this section
Sources:
46Novoseek, 52PharmGKB, 12DrugBank, 30IUPHAR, 25HMDB
See all sources

Compounds related to Myocardial Infarction 2 according to GeneCards/GeneDecks:

(show all 20)
idCompoundScoreTop Affiliating Genes
1delapril469.5PLAT, ACE
2manidipine469.5PLAT, ACE
3omapatrilat469.5ACE, PLAT
4quinapril46 52 1211.4PLAT, ACE
5enalaprilat469.4PLAT, ACE
6perindopril46 52 1211.4ACE, PLAT
7diltiazem46 30 52 1212.4PLAT, ACE
8hydrochlorothiazide46 30 52 25 1213.4PLAT, ACE
9enalapril46 52 1211.4ACE, PLAT
10clopidogrel46 52 25 1212.4PLAT, ACE
11nitroglycerin46 1210.4ACE, PLAT
12warfarin46 52 25 1212.3PLAT, ACE
13kininogen469.3PLAT, ACE
14fluvastatin46 52 30 1212.3ACE, PLAT
15losartan46 52 30 1212.2PLAT, ACE
16atorvastatin46 52 30 25 1213.2ACE, PLAT
17prostacyclin469.1PLAT, ACE
18cholesterol46 30 25 1212.1PLAT, ACE
19aspirin46 52 30 2512.0PLAT, ACE
20creatinine468.8PLAT, ACE

GO Terms for genes affiliated with Myocardial Infarction 2

About this section

Products for genes affiliated with Myocardial Infarction 2

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Myocardial Infarction 2

About this section
4CDC
14ExPASy
15FMA
23GTR
24HGMD
25HMDB
26ICD10
27ICD10 via Orphanet
28ICD9CM
30IUPHAR
31KEGG
36MeSH
37MESH via Orphanet
38MGI
41NCIt
42NDF-RT
45NINDS
46Novoseek
48OMIM
49OMIM via Orphanet
53PubMed
54QIAGEN
60SNOMED-CT via Orphanet
63UMLS
64UMLS via Orphanet